About 50 Mg Dasatinib Tablets
Reserve your bottle of our masterful 50 mg Dasatinib Tablets, a new release in the realm of supreme leukemia therapies. Available in customizable packaging of 60 tablets per bottle or strip (as illustrated), this first-class product-under the distinguished Sprycel brand or select generics-offers a prescription-only, high-purity tyrosine kinase inhibitor. Specifically crafted for targeted treatment of chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL), each oral tablet employs premium-quality Dasatinib (50 mg) for consistent, dependable results. Shelf life: 24-36 months. Distribute with confidence from India.
First-Class Targeted Leukemia Therapy
50 Mg Dasatinib Tablets are intended for oral use strictly under medical supervision. Ideal for the treatment of CML and Ph+ ALL, these tablets deliver targeted plant application within oncology settings. Their supreme features include high purity, prescription-only access, and precise kinase inhibition, ensuring masterful control over cancer cell proliferation. Their film-coated, odorless form guarantees consistent dosing, offering physicians and patients a reliable therapy option.
Premium Export Markets and Packaging Excellence
Our premium Dasatinib 50 mg tablets are shipped across major global markets, with a focus on timely delivery and secure transportation. Each shipment features robust packaging-either bottles or strips-preserving tablet quality throughout transit. We offer a practical sample policy to support customer confidence and facilitate initial assessment. Packaging is meticulously designed to prevent damage, moisture ingress, or product degradation, guaranteeing first-class presentation and client satisfaction.
FAQ's of 50 Mg Dasatinib Tablets:
Q: How should 50 Mg Dasatinib Tablets be stored?
A: Dasatinib tablets must be stored below 30C in their original packaging, away from moisture and light, to maintain supreme potency and shelf life.
Q: What is the recommended usage for these tablets?
A: These tablets are administered orally, as directed by a healthcare professional, specifically for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Q: When should Dasatinib 50 mg be avoided?
A: It is contraindicated in individuals with hypersensitivity to dasatinib or any of the excipients present in the formulation. Always consult your physician before initiating therapy.
Q: Where are these tablets primarily exported?
A: 50 Mg Dasatinib Tablets are distributed by leading exporters and suppliers in India, with shipments reaching major international markets, ensuring widespread access to first-class therapy.
Q: What benefits does this tyrosine kinase inhibitor offer?
A: Dasatinib 50 mg provides targeted inhibition of leukemia cell growth, offering patients a masterful advance in the management of CML and Ph+ ALL.
Q: How customizable is the packaging for bulk orders?
A: Packaging can be customized as per distributor or buyer requirements, ensuring flexibility within the premium packaging standards.